These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

697 related items for PubMed ID: 18581711

  • 1. [High and low density lipoprotein abnormalities in coronary patients with LDL-C at target and uncontrolled HDL-C and triglycerides].
    Posadas-Romero C, Posadas-Sánchez R, Juárez-Rojas JG, Medina-Urrutia A, Jorge-Galarza E, Cardoso-Saldaña G, Caracas-Portilla N, Mendoza-Peŕez E.
    Arch Cardiol Mex; 2008; 78(1):30-9. PubMed ID: 18581711
    [Abstract] [Full Text] [Related]

  • 2. Inflammatory/antiinflammatory properties of high-density lipoprotein distinguish patients from control subjects better than high-density lipoprotein cholesterol levels and are favorably affected by simvastatin treatment.
    Ansell BJ, Navab M, Hama S, Kamranpour N, Fonarow G, Hough G, Rahmani S, Mottahedeh R, Dave R, Reddy ST, Fogelman AM.
    Circulation; 2003 Dec 02; 108(22):2751-6. PubMed ID: 14638544
    [Abstract] [Full Text] [Related]

  • 3. Lability of serum low-density lipoprotein cholesterol levels during screening in subgroup of Air Force/Texas Coronary Atherosclerosis Prevention Study (AFCAPS/TexCAPS) cohort.
    Clearfield MB, Weis SE, Willis JM, Vasenius KA, McConathy WJ.
    J Am Osteopath Assoc; 2002 Jul 02; 102(7):377-84. PubMed ID: 12138952
    [Abstract] [Full Text] [Related]

  • 4. Relationship between plasma lipid concentrations and HDL subclasses.
    Yang Y, Yan B, Fu M, Xu Y, Tian Y.
    Clin Chim Acta; 2005 Apr 02; 354(1-2):49-58. PubMed ID: 15748599
    [Abstract] [Full Text] [Related]

  • 5. Low-density lipoprotein and high-density lipoprotein particle subclasses predict coronary events and are favorably changed by gemfibrozil therapy in the Veterans Affairs High-Density Lipoprotein Intervention Trial.
    Otvos JD, Collins D, Freedman DS, Shalaurova I, Schaefer EJ, McNamara JR, Bloomfield HE, Robins SJ.
    Circulation; 2006 Mar 28; 113(12):1556-63. PubMed ID: 16534013
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Relative atherogenicity and predictive value of non-high-density lipoprotein cholesterol for coronary heart disease.
    Miller M, Ginsberg HN, Schaefer EJ.
    Am J Cardiol; 2008 Apr 01; 101(7):1003-8. PubMed ID: 18359322
    [Abstract] [Full Text] [Related]

  • 10. Intensive insulin therapy reduces small dense low-density lipoprotein particles in patients with type 2 diabetes mellitus: relationship to triglyceride-rich lipoprotein subspecies.
    Hayashi T, Hirano T, Yamamoto T, Ito Y, Adachi M.
    Metabolism; 2006 Jul 01; 55(7):879-84. PubMed ID: 16784958
    [Abstract] [Full Text] [Related]

  • 11. Small dense low-density lipoprotein in renal transplant recipients: a potential target for prevention of cardiovascular complications?
    Badiou S, Garrigue V, Dupuy AM, Chong G, Cristol JP, Mourad G.
    Transplant Proc; 2006 Sep 01; 38(7):2314-6. PubMed ID: 16980076
    [Abstract] [Full Text] [Related]

  • 12. Effects of modifying triglycerides and triglyceride-rich lipoproteins on cardiovascular outcomes.
    Abdel-Maksoud M, Sazonov V, Gutkin SW, Hokanson JE.
    J Cardiovasc Pharmacol; 2008 Apr 01; 51(4):331-51. PubMed ID: 18427276
    [Abstract] [Full Text] [Related]

  • 13. High-density lipoprotein cholesterol and triglycerides as therapeutic targets for preventing and treating coronary artery disease.
    Gotto AM.
    Am Heart J; 2002 Dec 01; 144(6 Suppl):S33-42. PubMed ID: 12486414
    [Abstract] [Full Text] [Related]

  • 14. A 52-week, randomized, open-label, parallel-group comparison of the tolerability and effects of pitavastatin and atorvastatin on high-density lipoprotein cholesterol levels and glucose metabolism in Japanese patients with elevated levels of low-density lipoprotein cholesterol and glucose intolerance.
    Sasaki J, Ikeda Y, Kuribayashi T, Kajiwara K, Biro S, Yamamoto K, Ageta M, Kobori S, Saikawa T, Otonari T, Kono S.
    Clin Ther; 2008 Jun 01; 30(6):1089-101. PubMed ID: 18640465
    [Abstract] [Full Text] [Related]

  • 15. Cholesteryl ester transfer protein in metabolic syndrome.
    Sandhofer A, Kaser S, Ritsch A, Laimer M, Engl J, Paulweber B, Patsch JR, Ebenbichler CF.
    Obesity (Silver Spring); 2006 May 01; 14(5):812-8. PubMed ID: 16855190
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Triglyceride and high-density lipoprotein cholesterol: predicting disorders in parents from their children.
    Polonsky SM, Simbartl LA, Sprecher DL.
    Pediatrics; 1994 Dec 01; 94(6 Pt 1):824-31. PubMed ID: 7970997
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Lipid levels in patients hospitalized with coronary artery disease: an analysis of 136,905 hospitalizations in Get With The Guidelines.
    Sachdeva A, Cannon CP, Deedwania PC, Labresh KA, Smith SC, Dai D, Hernandez A, Fonarow GC.
    Am Heart J; 2009 Jan 01; 157(1):111-117.e2. PubMed ID: 19081406
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 35.